Related Experiment Videos

Chronic viral hepatitis

M H Chang1

  • 1Department of Pediatrics, College of Medicine, National Taiwan University, Taipei.

Insights

Hepatitis B virus (HBV) is a major cause of chronic hepatitis, primarily transmitted perinatally or through unsafe injections. Immunoprophylaxis at birth is key to preventing HBV and hepatitis D virus (HDV) infections.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis B, C, and D viruses can lead to chronic hepatitis in children and adults.
  • Hepatitis B virus (HBV) infection is the most common and significant, with perinatal transmission being a major factor in hyperendemic regions.
  • Horizontal transmission via non-sterile needles and intrafamilial spread also contribute significantly to chronic HBV carriers.

Purpose of the Study:

  • To summarize the transmission routes and natural course of chronic hepatitis B, C, and D infections.
  • To highlight the importance of immunoprophylaxis for preventing HBV and HDV.
  • To discuss current strategies and future needs for preventing hepatitis C virus (HCV) infection in children.

Main Methods:

  • Review of existing literature on hepatitis virus transmission and prevention.
  • Analysis of epidemiological data regarding perinatal and horizontal transmission of HBV.
  • Discussion of immunoprophylaxis efficacy and vaccination research for HCV.

Main Results:

  • Perinatal transmission accounts for 40-45% of chronic HBV infections in hyperendemic areas.
  • Host immune response leads to HBV and hepatitis B e antigen (HBeAg) clearance, often accompanied by liver damage.
  • Blood product screening has reduced post-transfusion HCV infections, but vaccination for sporadic cases is still under development.

Conclusions:

  • Immunoprophylaxis initiated at birth is the most effective strategy for eliminating HBV and preventing HDV infections.
  • HCV infection in children is primarily associated with high-risk exposures, including blood products and maternal viremia.
  • Development of an effective HCV vaccine is crucial for preventing sporadic infections.

Related Concept Videos